Exact Sciences
EXAS
#1097
Rank
$20.02 B
Marketcap
$104.91
Share price
0.00%
Change (1 day)
142.34%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Market capitalization of Exact Sciences (EXAS)

Market cap: $20.02 Billion USD

As of March 2026 Exact Sciences has a market cap of $20.02 Billion USD. This makes Exact Sciences the world's 1097th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exact Sciences from 2001 to 2026

End of year Market Cap

Year Marketcap Change
2026$20.02 B3.9%
2025$19.27 B80.96%
2024$10.65 B-20.39%
2023$13.37 B52.09%
2022$8.79 B-34.92%
2021$13.51 B-32.18%
2020$19.92 B45.98%
2019$13.65 B75.63%
2018$7.77 B23.57%
2017$6.29 B334.33%
2016$1.44 B62.32%
2015$0.89 B-63.31%
2014$2.43 B191.21%
2013$0.83 B23.39%
2012$0.67 B57.47%
2011$0.42 B37.78%
2010$0.31 B159.03%
2009$0.12 B675.37%
2008$15.53 M-82.23%
2007$87.39 M15.32%
2006$75.78 M29.71%
2005$58.42 M-41.97%
2004$0.10 B-48.48%
2003$0.19 B-5.4%
2002$0.20 B7.42%
2001$0.19 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
$113.78 B 468.17%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
$2.41 B-87.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
$0.95 B-95.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
$0.40 B-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
$1.14 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA